Azenta (NASDAQ:AZTA - Get Free Report) is expected to be issuing its Q2 2025 quarterly earnings data before the market opens on Wednesday, May 7th. Analysts expect Azenta to post earnings of $0.09 per share and revenue of $140.87 million for the quarter.
Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, analysts expect Azenta to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Azenta Stock Performance
Shares of NASDAQ AZTA traded down $0.57 during trading on Monday, hitting $26.39. The company had a trading volume of 296,079 shares, compared to its average volume of 653,355. Azenta has a 52 week low of $24.06 and a 52 week high of $63.58. The business's 50-day moving average is $33.14 and its 200 day moving average is $42.61. The company has a market cap of $1.21 billion, a P/E ratio of -8.83 and a beta of 1.66.
Analysts Set New Price Targets
A number of equities analysts recently weighed in on AZTA shares. TD Cowen upgraded Azenta to a "hold" rating in a research report on Thursday, February 27th. Evercore ISI upped their target price on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Finally, Needham & Company LLC raised their price target on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th.
Get Our Latest Report on Azenta
Azenta Company Profile
(
Get Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
